Ahmed 
Tremelimumab is marketed by name, Imjudo. It is a CTLA-4 inhibitor that has been approved for the treatment of unresectable HCC and non-small-cell carcinoma. What is CTLA-4? CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) is a protein receptor that is expressed on the surface of T-cells (a type of immune cell). It functions as a negative regulator … Read more
Irritable Bowel Syndrome (IBS) is the most common gastrointestinal disorder. Many over-the-counter treatment options are now available to ease the unpleasant symptoms of IBS. But it often gets confusing to choose the right medicine according to your IBS type. A gastrointestinal (GI) illness called irritable bowel syndrome (IBS) is characterized by recurring episodes of abdominal … Read more
Ozempic (Semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood sugar levels and reduce appetite, leading to weight loss. However, once you stop taking the medication, your appetite and blood sugar levels may return to pre-treatment levels, which could cause weight gain. It’s important to remember that weight loss and weight management … Read more
7 Benefits Of Ozempic Injection For Diabetics are enlisted here. Ozempic is a new and improved prescription drug designed to help reduce blood sugar levels in individuals with diabetes. Ozempic is an FDA-approved medication used to treat type 2 diabetes. It helps to lower the amount of glucose in the blood and provides numerous other … Read more
Tysabri contains “Natalizumab” considered an evolution in the management of many autoimmune diseases. It is manufactured by Biogen Company and got FDA approval in 2004. In 2005 the drug was voluntarily withdrawn from the U.S. market when cases of progressive multifocal leukoencephalopathy were reported. However, it was again approved by FDA in 2006 due to … Read more
Tofacitinib is an oral Janus Kinase Inhibitor. Because of its unique and novel mechanism of action, it is one of the potent JAK Inhibitors. It was approved by the FDA in 2012. It is available in two formulations: Immediate Release as Xeljanz, and The Extended Release Oral Tablets as Xeljanz XR Tofacitinib is a Janus … Read more
Upadacitinib is among the novel class of medicines with a unique mechanism of action (MOA). It is available by the brand name, Rinvoq that has been approved in 2019 by the FDA. Among the biological medications, it is one of the few medicines that are available as oral tablet formulations with once-daily dosing. Rinvoq Indications: … Read more
Dupixent side effects are generally mild in severity. Because Dupixent is a very targeted drug, it has little impact on other organ systems. What is Dupixent? Dupixent is the brand name of Dupilumab. Dupixent is a monoclonal antibody that targets human IL-4Rα (Interleukin 4 receptor alpha). By binding to IL-4Rα, it inhibits the signaling pathway … Read more
Rinvoq side effects are primarily related to the immune dysfunction caused by the drug. Thus, the most serious side effects of Rinvoq are related to infections and cancers which could arise as a result of long-term use of Rinvoq. What is Rinvoq? Rinvoq is the market name of Upadacitinib. It belongs to the class of … Read more
Tirzepatide is a dual GLP-1 and GIP analog that has got FDA approval for the treatment of patients with Type 2 Diabetes Mellitus. It has been associated with marked weight loss of approximately 22% which is even greater than Wegovy, an FDA-approved weight loss drug, however, Tirzepatide’s FDA approval as a weight loss drug is … Read more